Abiopharma

🔍 Banon Shay (Director)

Company: Elastic N.V. (ESTC)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Sold 108,423 shares of Ordinary Shares at $96.17 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,946,555.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 87,423 shares of Ordinary Shares at $96.77 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,859,132.00 | transaction_form_type: 4 | Footnotes: F2, F9
• Sold 4,154 shares of Ordinary Shares at $97.75 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,854,978.00 | transaction_form_type: 4 | Footnotes: F3, F9
• Sold 97,599 shares of Ordinary Shares at $92.48 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,757,379.00 | transaction_form_type: 4 | Footnotes: F4, F9
• Sold 13,528 shares of Ordinary Shares at $93.47 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,743,851.00 | transaction_form_type: 4 | Footnotes: F5, F9
• Sold 97,199 shares of Ordinary Shares at $89.71 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,646,652.00 | transaction_form_type: 4 | Footnotes: F6, F9
• Sold 42,456 shares of Ordinary Shares at $90.69 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,604,196.00 | transaction_form_type: 4 | Footnotes: F7, F9
• Sold 25,516 shares of Ordinary Shares at $91.67 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,578,680.00 | transaction_form_type: 4 | Footnotes: F8, F9
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-31 | Code: H | shares_owned_after: 4,417,140.00

Footnotes:

• F1: The price reported in Column 4 represents a weighted average sales price of $96.1695. These shares were sold in multiple transactions at prices ranging from $95.55 to $96.5471, inclusive. The reporting person undertakes to provide to Elastic N.V., any security holder of Elastic N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 1 through 8 to this Form 4.
• F2: The price reported in Column 4 represents a weighted average sales price of $96.7658. These shares were sold in multiple transactions at prices ranging from $96.55 to $97.50, inclusive.
• F3: The price reported in Column 4 represents a weighted average sales price of $97.7467. These shares were sold in multiple transactions at prices ranging from $97.59 to $97.86, inclusive.
• F4: The price reported in Column 4 represents a weighted average sales price of $92.476. These shares were sold in multiple transactions at prices ranging from $92.13 to $93.11, inclusive.
• F5: The price reported in Column 4 represents a weighted average sales price of $93.4653. These shares were sold in multiple transactions at prices ranging from $93.15 to $93.75, inclusive.
• F6: The price reported in Column 4 represents a weighted average sales price of $89.7063. These shares were sold in multiple transactions at prices ranging from $89.36 to $90.34, inclusive.
• F7: The price reported in Column 4 represents a weighted average sales price of $90.6922. These shares were sold in multiple transactions at prices ranging from $90.40 to $91.11, inclusive.
• F8: The price reported in Column 4 represents a weighted average sales price of $91.6710. These shares were sold in multiple transactions at prices ranging from $91.50 to $92.09, inclusive.
• F9: Held by a fund for joint account (the "fund") owned by the Reporting Person's three minor children. The Reporting Person continues to have sole control of such fund and remains the indirect beneficial owner of the shares owned by such fund.